News

The late-June announcement that Ireland is joining the Beneluxa Initiative on Pharmaceutical Policy might suggest renewed vigour for the drive to equip national governments with more clout in their pricing negotiations with international drug firms.

The general assumption that the Policy 0070 data releases were public data releases can be challenged since there is a mechanism to enforce the ToU, and this mechanism will continue to exist after the Agency moves to the Netherlands.

How much does the EU really care about health, and about the infrastructure that is a precondition to successful healthcare and healthcare innovation?

The right-to-try gale is now blowing at full strength in the US and is likely to prove a straw in the wind that could become a haystack.

In this article, we will demonstrate a methodology that resulted in improving CRA performance.